• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ERCC1 expression in triple negative breast carcinoma: the paradox revisited.

作者信息

Sidoni Angelo, Cartaginese Fabio, Colozza Mariantonietta, Gori Stefania, Crinó Lucio

出版信息

Breast Cancer Res Treat. 2008 Oct;111(3):569-70. doi: 10.1007/s10549-007-9804-4. Epub 2007 Nov 7.

DOI:10.1007/s10549-007-9804-4
PMID:17987380
Abstract
摘要

相似文献

1
ERCC1 expression in triple negative breast carcinoma: the paradox revisited.三阴性乳腺癌中ERCC1的表达：重新审视这一矛盾现象
Breast Cancer Res Treat. 2008 Oct;111(3):569-70. doi: 10.1007/s10549-007-9804-4. Epub 2007 Nov 7.
2
[Therapeutic targeting in breast cancer].[乳腺癌的治疗靶点]
Ann Pathol. 2009 Nov;29 Spec No 1:S71-3. doi: 10.1016/j.annpat.2009.07.047. Epub 2009 Oct 21.
3
Triple negative, basal cell type and EGFR positive invasive breast carcinoma in Kuwaiti and British patients.科威特和英国患者中的三阴性、基底细胞型及表皮生长因子受体阳性浸润性乳腺癌
Breast J. 2009 Jan-Feb;15(1):109-11. doi: 10.1111/j.1524-4741.2008.00682.x. Epub 2008 Dec 9.
4
Potential chemotherapy options in the triple negative subtype of breast cancer.三阴性乳腺癌亚型中的潜在化疗方案。
J Clin Oncol. 2007 Apr 1;25(10):1294-5; author reply 1295-6. doi: 10.1200/JCO.2006.10.0883.
5
Triple negative breast cancer: clinicopathological characteristics and treatment strategies.三阴性乳腺癌：临床病理特征与治疗策略
Breast Cancer. 2009;16(4):252-3. doi: 10.1007/s12282-009-0140-x.
6
Triple negative and basal-like breast cancer in East Africa.东非的三阴性和基底样乳腺癌。
Breast J. 2011 Jul-Aug;17(4):438-40. doi: 10.1111/j.1524-4741.2011.01096.x.
7
Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer.丝裂原活化蛋白激酶（MAPK）表达水平较低与激素受体阴性乳腺癌患者的蒽环类耐药及生存率降低有关。
Cancer Invest. 2008 Aug;26(7):671-9. doi: 10.1080/07357900801891628.
8
Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.微小腺腺病及向原位癌和浸润癌转变的临床、组织病理学及免疫组化特征。
Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.
9
Clinicopathological characteristics of triple-negative breast cancers.三阴性乳腺癌的临床病理特征
Breast Cancer. 2009;16(4):254-9. doi: 10.1007/s12282-009-0153-5. Epub 2009 Aug 6.
10
Triple negative endometrial cancer may be more sensitive to platinum based chemotherapy.三阴性子宫内膜癌可能对铂类化疗更敏感。
J BUON. 2013 Jan-Mar;18(1):289.

引用本文的文献

1
Predictive Value of Excision Repair Cross Complementation Group 1 (ERCC1) by Immunohistochemistry for Determining Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancers.免疫组织化学检测切除修复交叉互补基因1（ERCC1）对三阴性乳腺癌新辅助化疗反应的预测价值
Breast J. 2025 Feb 18;2025:8410670. doi: 10.1155/tbj/8410670. eCollection 2025.
2
ERCC1 is a potential biomarker for predicting prognosis, immunotherapy, chemotherapy efficacy, and expression validation in HER2 over-expressing breast cancer.ERCC1是预测HER2过表达乳腺癌预后、免疫治疗、化疗疗效及表达验证的潜在生物标志物。
Front Oncol. 2022 Oct 20;12:955719. doi: 10.3389/fonc.2022.955719. eCollection 2022.
3
High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer.
高切除修复交叉互补组1表达与乳腺癌的良好预后因素相关。
Oncol Lett. 2017 Oct;14(4):4995-5003. doi: 10.3892/ol.2017.6737. Epub 2017 Aug 9.
4
ERCC1 Expression in Metastatic Triple Negative Breast Cancer Patients Treated with Platinum-Based Chemotherapy.接受铂类化疗的转移性三阴性乳腺癌患者的ERCC1表达情况
Asian Pac J Cancer Prev. 2017 Feb 1;18(2):507-513. doi: 10.22034/APJCP.2017.18.2.507.
5
ERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosis.新辅助化疗治疗的乳腺肿瘤中ERCC1和端粒状态及其与患者预后的关联
J Pathol Clin Res. 2016 Jul 13;2(4):234-246. doi: 10.1002/cjp2.52. eCollection 2016 Oct.
6
Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.采用新型检测技术，检测局部晚期/炎症性和 IV 期乳腺癌患者循环肿瘤细胞与原发和转移部位肿瘤组织中多种生物标志物的表达。
Breast Cancer Res Treat. 2011 Jul;128(1):155-63. doi: 10.1007/s10549-011-1508-0. Epub 2011 Apr 16.